NO995389L - COX-2 selective carprofen for the treatment of pain and inflammation in dogs - Google Patents

COX-2 selective carprofen for the treatment of pain and inflammation in dogs

Info

Publication number
NO995389L
NO995389L NO995389A NO995389A NO995389L NO 995389 L NO995389 L NO 995389L NO 995389 A NO995389 A NO 995389A NO 995389 A NO995389 A NO 995389A NO 995389 L NO995389 L NO 995389L
Authority
NO
Norway
Prior art keywords
carprofen
cox
dogs
inflammation
pain
Prior art date
Application number
NO995389A
Other languages
Norwegian (no)
Other versions
NO995389D0 (en
Inventor
Kristin Marie Lundby
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO995389D0 publication Critical patent/NO995389D0/en
Publication of NO995389L publication Critical patent/NO995389L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
NO995389A 1997-05-05 1999-11-04 COX-2 selective carprofen for the treatment of pain and inflammation in dogs NO995389L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (2)

Publication Number Publication Date
NO995389D0 NO995389D0 (en) 1999-11-04
NO995389L true NO995389L (en) 2000-01-04

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995389A NO995389L (en) 1997-05-05 1999-11-04 COX-2 selective carprofen for the treatment of pain and inflammation in dogs

Country Status (32)

Country Link
EP (1) EP0988034A1 (en)
JP (1) JP2000513020A (en)
KR (2) KR20010012300A (en)
CN (1) CN1255059A (en)
AP (1) AP9801234A0 (en)
AR (2) AR011726A1 (en)
AU (1) AU6932198A (en)
BG (1) BG103852A (en)
BR (1) BR9808720A (en)
CA (1) CA2288759A1 (en)
DZ (1) DZ2479A1 (en)
EA (1) EA003696B1 (en)
GT (1) GT199800063A (en)
HR (1) HRP980244A2 (en)
HU (1) HUP0001286A3 (en)
ID (1) ID21311A (en)
IL (1) IL132570A0 (en)
IS (1) IS5220A (en)
MA (1) MA26491A1 (en)
NO (1) NO995389L (en)
NZ (1) NZ500183A (en)
OA (1) OA11213A (en)
PA (1) PA8450601A1 (en)
PE (1) PE72599A1 (en)
PL (1) PL337003A1 (en)
SK (1) SK148199A3 (en)
TN (1) TNSN98059A1 (en)
TW (1) TW590773B (en)
UY (1) UY24989A1 (en)
WO (1) WO1998050033A1 (en)
YU (1) YU55899A (en)
ZA (1) ZA983722B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
CA2347365A1 (en) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
DE60023119T2 (en) * 1999-03-10 2006-07-20 G.D. Searle Llc COMPOSITIONS FOR THE ADMINISTRATION OF A CYCLOOXYGENASE-2 HEMMER TO ANIMALS
WO2001034204A1 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
WO2001087343A2 (en) * 2000-05-15 2001-11-22 Merck Frosst Canada & Co. Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
PL206268B1 (en) 2000-06-13 2010-07-30 Wyethwyeth Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
EP1307585B1 (en) 2000-08-07 2009-01-21 Vanderbilt University Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites
WO2003007875A2 (en) * 2001-07-16 2003-01-30 Hoegestaett Edward Compounds with analgesic, antipyretic and/or anti-inflammatory activity
ES2275218T3 (en) 2003-05-07 2007-06-01 Osteologix A/S HYDROSOLUBLE STRONTIUM SALTS FOR THE TREATMENT OF CARTILAGOS AND / OR BONE AFFECTIONS.
MXPA06001288A (en) * 2003-07-31 2006-04-11 Upjohn Co Dispersible formulation of an anti-inflammatory agent.
EA200702280A1 (en) * 2005-05-20 2008-04-28 Пфайзер Лимитед SYNERGISTIC COMBINATIONS
JP2010523554A (en) 2007-04-04 2010-07-15 シグモイド・ファーマ・リミテッド Pharmaceutical composition of tacrolimus
US8951570B2 (en) 2007-04-26 2015-02-10 Sigmoid Pharma Limited Manufacture of multiple minicapsules
GB2483815B (en) 2009-05-18 2013-12-25 Sigmoid Pharma Ltd Composition comprising oil drops
CN107582526A (en) 2009-08-12 2018-01-16 希格默伊德药业有限公司 Immune regulation composite comprising polymer substrate and oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CN105939713A (en) 2014-03-06 2016-09-14 阿莱塔纳治疗学股份有限公司 Compositions of grapiprant and methods for using same
AU2015341695B2 (en) 2014-11-07 2021-07-08 Sublimity Therapeutics Limited Compositions comprising cyclosporin
WO2016112312A1 (en) * 2015-01-09 2016-07-14 Jaguar Animal Health Methods of treating diarrhea in companion animals
WO2021195346A1 (en) * 2020-03-25 2021-09-30 Sri International Lipoxygenase inhibitors
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (en) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 Pharmaceutical composition for preventing or treating keloid or hypertrophic scar comprising Benzbromarone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
HUP0001286A2 (en) 2000-11-28
GT199800063A (en) 1999-10-26
CA2288759A1 (en) 1998-11-12
WO1998050033A1 (en) 1998-11-12
PL337003A1 (en) 2000-07-31
EA199900895A1 (en) 2000-06-26
NZ500183A (en) 2002-04-26
ZA983722B (en) 1999-11-04
KR20010012300A (en) 2001-02-15
DZ2479A1 (en) 2003-02-01
AR011726A1 (en) 2000-08-30
AP9801234A0 (en) 1999-11-04
PE72599A1 (en) 1999-08-12
PA8450601A1 (en) 2000-05-24
MA26491A1 (en) 2004-12-20
NO995389D0 (en) 1999-11-04
EA003696B1 (en) 2003-08-28
OA11213A (en) 2003-07-14
SK148199A3 (en) 2001-09-11
IS5220A (en) 1999-10-19
AR039628A2 (en) 2005-03-02
YU55899A (en) 2003-08-29
KR20040004406A (en) 2004-01-13
UY24989A1 (en) 2001-10-25
AU6932198A (en) 1998-11-27
HUP0001286A3 (en) 2000-12-28
CN1255059A (en) 2000-05-31
TW590773B (en) 2004-06-11
EP0988034A1 (en) 2000-03-29
ID21311A (en) 1999-05-20
HRP980244A2 (en) 1999-02-28
JP2000513020A (en) 2000-10-03
BG103852A (en) 2000-06-30
BR9808720A (en) 2000-07-11
IL132570A0 (en) 2001-03-19
TNSN98059A1 (en) 2005-03-15

Similar Documents

Publication Publication Date Title
NO995389D0 (en) COX-2 selective carprofen for the treatment of pain and inflammation in dogs
NO20005190L (en) Therapeutic angiogenic factors and methods for their use
NO20014560D0 (en) Quinasolines and their therapeutic use
DE69825447D1 (en) DERMATOLOGICAL TREATMENT DEVICE
IS5405A (en) Prostaglandin agonists and their use in the treatment of bone disorders
ID18741A (en) Nicotinic Substance in Therapy
DE69630947D1 (en) PAIN TREATMENT AGENTS
NO20022656L (en) Caspase Inhibitors and Their Use
EE05073B1 (en) Retigabine for use in the treatment of neuropathic pain
DE69805438D1 (en) MIXING AND CHARGING OPENING FOR MEDICAL TREATMENT
EE200000366A (en) Apparatus and method for treating body tissues with electricity or drugs
EE9900421A (en) Domestic wastewater treatment system and method
DE60019490D1 (en) Fuel conveyor and treatment device
NO983576L (en) Well treatment fluids and methods
NO20005179D0 (en) Drug treatment
DE69701250D1 (en) Animal treatment device
NO20012738D0 (en) Therapeutic products and their use
PT932400E (en) DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN
ID24060A (en) IMPROVED ANIMAL SKIN TREATMENT
ITMI20001555A0 (en) ELECTROCHEMICAL TREATMENT PROCEDURE AND DEVICE
PT1178981E (en) SUBSTITUTED 3-PYRIDYL-4-ARYLIPYROLS AND THERAPEUTIC AND PROFILACTIC METHODS
DK0915655T3 (en) Method and composition for the treatment of parasites in animal environments
AU5388299A (en) Antibodies for use in targeted and temporary treatment of humans and animals
DE69932577D1 (en) Bar treatment device and bar charger
ID30458A (en) OSANETAN IN TREATMENT OF SOUL DISORDERS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application